Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin-facilitated Treatment for Chronic Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05068791

Organisation Name: University of Alabama at Birmingham

Overal Status: Not yet recruiting

Start Date: November 1, 2021

Last Update: October 6, 2021

Lead Sponsor: University of Alabama at Birmingham

Brief Summary: The primary purpose of this study is to preliminarily estimate the efficacy of psilocybin-facilitated treatment for fibromyalgia. Investigators will assess the impact of psilocybin-facilitated treatment on pain, fatigue, and other fibromyalgia symptoms, in addition to the level of functioning and quality of life. Investigators will also evaluate potential mediators of treatment (e.g., treatment expectations, pain characteristics, personality, beliefs/cognitions, emotions). Investigators hypothesize psilocybin treatment will significantly reduce symptom severity in fibromyalgia patients.

Conditions:
  • Fibromyalgia, Primary


Total execution time in seconds: 0.40264892578125